$103.92▲ 2.35 (2.31%)
Real-time prices · US MarketsQ·Score
Underperform
4.6 / 10
Clean balance sheet with low leverage (0.0× debt-to-equity).
currently unprofitable (-40% margin).
Quality
1.2
Health
8.2
Growth
2.6
Valuation
5.3
Sentiment
7.3
Analyst Target
$130.51
▲ +25.6% from current
Price Chart
Latest News
Fundamentals
Trailing P/E
—
price-to-earnings
Forward P/E
-23.3×
next 12 months est.
Market Cap
$26.3B
market capitalization
Div Yield
—
dividend yield
Profit Margin
-39.6%
net profit margin
Gross Margin
78.7%
revenue minus COGS
ROE
-5.9%
return on equity
Beta
1.59
vs S&P 500
Price / Book
—
P/B ratio
52-Week Range
$80 — $124
annual min — max
EPS — Estimate vs Actual
Frequently Asked Questions
Is BNTX a good stock to buy right now?
Based on our Q·Score of 4.6/10, BioNTech SE is rated "Underperform". Clean balance sheet with low leverage (0.0× debt-to-equity). Main risk to consider: currently unprofitable (-40% margin). This analysis is based on fundamentals, analyst consensus, and valuation data, and should not be considered financial advice.
What is the analyst price target for BNTX?
The consensus price target for BNTX is $130.51, based on the recommendations of 18 Wall Street analysts. This implies 25.6% upside from the current price of $103.92.
Is BNTX overvalued or undervalued?
BioNTech SE (BNTX) appears fairly valued at current levels relative to analyst targets and sector peers. Analysts see 26% upside to their $130.51 consensus target.
When does BioNTech SE report its next earnings?
BioNTech SE is scheduled to report earnings in 5 days, on May 5, 2026.
What is BioNTech SE's profit margin?
BioNTech SE has a net profit margin of -39.6%, indicating the company is currently operating at a net loss. Its gross margin stands at 78.7%, indicating a high-margin business model.
Is BioNTech SE's revenue growing?
BioNTech SE is reporting revenue declining 23.7% year-over-year.
How much debt does BioNTech SE have?
BioNTech SE has a debt-to-equity ratio of 0.01×, reflecting a very low debt-to-equity ratio, signalling a conservatively financed balance sheet. Its current ratio is 7.54×, indicating comfortable short-term liquidity.